Citations 2
Amplifying Our Voices: Fostering Advocacy in Infectious Diseases Fellowship
Paras, Molly L , Stead, Wendy , Bisono, Bismarck , Pottinger, Paul S. , Aziz, Rania S Abdel, Aziz, Mariam, Balba, Gayle , Blackburn, Brian G. , Butt, Saira , Chow, Brian , Graber, Christopher J. , Muñoz-Gómez, Sigridh , Pellegrino, Rachael , Schultz, Sara , Shnekendorf, Rachel, Jezek, Amanda, Martin, Allan , Group, For the Infectious Diseases Society of America Training Program Directors Community of Practice and Working, Angarone, Michael , Arnold, Forest, Bartash, Rachel , Bhanot, Nitin , Bhatt, Pinki J. , Bittner, Marvin J. , Blyth, Dana M , Carey, A., Cerne, Carlie, Donaghy, Henry, Echevarria, Leonor, Jose, Jo-Ann, Kodiyanplakkal, Rosy Priya , Román, F, Garcia, Luis Medina, Lora, Alfredo J Mena , Miko, Benjamin A. , Mitra, Subhashis , Osorio, Georgina, Patel, Mukesh, Pinargote, Paulette, Salas, Natalie Mariam , Sellers, Christopher J., Tang, Michael , Tischendorf, Jessica S , Trinh, Sonya, Viehman, J Alex, Vielemeyer, Ole, Wooten, Darcy , Bisono Garcia, Bismarck , Martin, Arlene , Luther, Vera P , Pottinger, Paul , Aziz, Rabita, Luther, Vera , Group, For the Infectious Diseases Society of America Training Program Directors Community of Practice and Working, Arnold, Forest, Bhowmick, Tanaya , Carey, Adrienne L, Dare, Ryan K , Jose, Jo-Ann, Gil, Raul Macias , Roman, Francisco Machiavello, Garcia, Luis Medina, Razonable, Raymund R. , Trinh, Sonya, Viehman, J Alex
Open Forum Infectious Diseases | November 9, 2025 | Volume: 12 | Issue: 12 | Pages: No page available
Abstract Advocacy has long been at the core of the infectious diseases (ID) field, with clinicians and researchers advocating to ensure patients can access the care they need on an individual and global scale. The Infectious Diseases Society of America Training Program Directors’ (PD) Committee met in 2024 and discussed ways that advocacy is and should be incorporated into fellowship training, as well as highlighted the role PDs play in advocating for their trainees. Policies with a negative impact on ID clinical care, public health, and research underscore the importance of mobilizing the field of ID to advocate for the patients and communities we serve, as well as for ourselves. This paper presents ideas generated at this meeting and is meant to serve as a reference for ID PDs, as well as the wider ID community, as a call to action for teaching and participating in advocacy work.
Leveraging Existing and Soon-to-Be-Available Novel Diagnostics for Optimizing Outpatient Antibiotic Stewardship in Patients With Respiratory Tract Infections
Cawcutt, Kelly , Patel, Robin , Gerber, Jeff, Caliendo, Angela M. , Cosgrove, Sara E. , Ashley, Elizabeth Dodds , Garzaro, Piero, Lautenbach, Ebbing , Banerjee, Ritu , Boyd, Sarah E, File, Thomas M. , Livorsi, Daniel J. , May, Larissa, Moehring, Rebekah W. , Nolte, Frederick S. , Szymczak, Julie, Timbrook, Tristan T. , Tsalik, Ephraim L. , Virk, Abinash, Jezek, Amanda, Levy, Jaclyn, Zetts, Rachel M , Hicks, Lauri A. , Wiecek, Joanna , Nettles, Rick, Wittek, James, Murray, Patrick, Ginocchio, Christine C. , Cawcutt, Kelly , Patel, Robin , Gerber, Jeffrey S. , Miller, Melissa B. , Ebell, Mark H. , Graf, Erin H. , Keller, Sara C. , Koo, Sophia , Pinsky, Benjamin A. , Virk, Abinash
Clinical Infectious Diseases | December 2, 2020 | Volume: 72 | Issue: 12 | Pages: e1115-e1121
Abstract Respiratory tract infections (RTIs) drive many outpatient encounters and, despite being predominantly viral, are associated with high rates of antibiotic prescriptions. With rising antibacterial resistance, optimization of prescribing of antibiotics in outpatients with RTIs is a critical need. Fortunately, this challenge arises at a time of increasing availability of novel RTI diagnostics to help discern which patients have bacterial infections warranting treatment. Effective implementation of antibiotic stewardship is needed, but optimal approaches for ambulatory settings are unknown. Future research needs are reviewed in this summary of a research summit convened by the Infectious Diseases Society of America in the fall of 2019.